OC41 在患有囊性纤维化相关性肝病的儿童中使用三联（Elexacaftor/Tezacaftor/Ivacaftor）囊性纤维化跨膜传导调节剂

{"title":"OC41 在患有囊性纤维化相关性肝病的儿童中使用三联（Elexacaftor/Tezacaftor/Ivacaftor）囊性纤维化跨膜传导调节剂","authors":"J. Valamparampil, Benjamin Davies, Maya Desai, Indra Van Mourik","doi":"10.1136/flgastro-2024-bspghan.40","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":6892,"journal":{"name":"Abstracts","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"OC41 Use of triple (Elexacaftor/Tezacaftor/Ivacaftor) cystic fibrosis transmembrane conductance regulator modulator in children with cystic fibrosis associated liver disease\",\"authors\":\"J. Valamparampil, Benjamin Davies, Maya Desai, Indra Van Mourik\",\"doi\":\"10.1136/flgastro-2024-bspghan.40\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":6892,\"journal\":{\"name\":\"Abstracts\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/flgastro-2024-bspghan.40\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/flgastro-2024-bspghan.40","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}